(Sharecast News) - Page Group: Morgan Stanley downgrades to underweight with a target price of 545p.
Auto Trader Group: Berenberg reiterates hold with a target price of 650p.
Meggitt: Berenberg reiterates buy with a target price of 560p.
GlaxoSmithKline: Berenberg reiterates buy with a target price of 1,570p.
IG Design Group: Canaccord reiterates buy with a target price of 790p.
K3 Capital Group: Canaccord reiterates buy with a target price of 398p.
CountrySide Properties: Deutsche Bank reiterates buy with a target price of 521p.
Future: Deutsche Bank reiterates buy with a target price of 3,321p.
Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,200p.
Serco Group: Barclays reiterates overweight with a target price of 180p.
Robert Walters: Credit Suisse reiterates neutral with a target price of 750p.
SThree: Credit Suisse reiterates outperform with a target price of 495p.
Hays: Morgan Stanley reiterates overweight with a target price of 185p.
ITM Power: RBC Capital Markets reiterates sector perform with a target price of 310p.
Anglo American: RBC Capital Markets downgrades to sector perform with a target price of 3,400p.
Astrazeneca (AZN)
Anglo American (AAL)
Itm Power (ITM)
Robert Walters (RWA)
Hays (HAS)
Auto Trader (AUTO)
Serco (SRP)
Future (FUTR)
Glaxosmithkline (GSK)
K3 Business Technology Group (KBT)
SThree (STEM)3 May 2024 12:17
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)